Separately, TheStreet lowered Utah Medical Products from a “b” rating to a “c” rating in a research report on Tuesday, July 28th.
NASDAQ UTMD opened at $81.50 on Friday. The company has a 50-day moving average of $89.13 and a 200-day moving average of $89.89. The company has a market cap of $296.86 million, a P/E ratio of 25.47 and a beta of 0.39. Utah Medical Products has a 12 month low of $75.33 and a 12 month high of $112.26.
In other Utah Medical Products news, Director Barbara A. Payne sold 770 shares of Utah Medical Products stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $92.00, for a total transaction of $70,840.00. Following the transaction, the director now owns 16,338 shares of the company’s stock, valued at approximately $1,503,096. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Kevin L. Cornwell sold 5,000 shares of the business’s stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $106.42, for a total transaction of $532,100.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 6,770 shares of company stock worth $710,940. 7.30% of the stock is owned by company insiders.
Institutional investors have recently bought and sold shares of the company. Advisor Group Inc. acquired a new stake in shares of Utah Medical Products during the 4th quarter worth approximately $38,000. Advisor Group Holdings Inc. acquired a new stake in Utah Medical Products in the 1st quarter valued at about $33,000. Citigroup Inc. raised its position in Utah Medical Products by 47.7% in the 1st quarter. Citigroup Inc. now owns 1,044 shares of the medical instruments supplier’s stock worth $98,000 after purchasing an additional 337 shares during the last quarter. BNP Paribas Arbitrage SA lifted its stake in shares of Utah Medical Products by 98.7% during the first quarter. BNP Paribas Arbitrage SA now owns 1,085 shares of the medical instruments supplier’s stock valued at $102,000 after acquiring an additional 539 shares during the period. Finally, SG Americas Securities LLC bought a new position in shares of Utah Medical Products in the 1st quarter valued at about $128,000. Institutional investors and hedge funds own 72.04% of the company’s stock.
Utah Medical Products Company Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.
Featured Article: Options Trading – What is a Straddle?
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.